ONTOLOGY REPORT - ANNOTATIONS
| Term: | dexamethasone |
|
| Accession: | CHEBI:41879
|
browse the term
|
| Definition: | A fluorinated steroid that has formula C22H29FO5. |
| Synonyms: | exact_synonym: | 9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione |
| | related_synonym: | 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone; 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol; 9alpha-Fluoro-16alpha-methylprednisolone; C22H29FO5; Decadron; InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1; InChIKey=UREBDLICKHMUKA-CXSFZGCWSA-N; [H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C; dexametasona; dexamethasonum |
| | alt_id: | CHEBI:41873; CHEBI:4461 |
| | xref_casrn: | 50-02-2 |
| | xref: | Beilstein:2066652 "Beilstein Registry Number"; ChEMBL:465281 "ChEMBL COMPOUND"; ChemIDplus:50-02-2 "CAS Registry Number"; DrugBank:DB01234 "DrugBank"; KEGG DRUG:D00292 "KEGG DRUG" |
| | xref_mesh: | MESH:D003907 |
| | xref: | Patent:DE1113690 "Patent"; Patent:GB869511 "Patent"; Patent:US3007923 "Patent"; Wikipedia:Dexamethasone "Wikipedia" |
|
|
dexamethasone
|
| G |
A2m |
alpha-2-macroglobulin |
|
decreases expression |
ISO |
6 |
121,586,191 |
121,629,256 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
increases expression |
ISO |
4 |
53,043,661 |
53,172,767 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions |
EXP |
4 |
53,043,661 |
53,172,767 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions |
ISO |
4 |
53,043,661 |
53,172,767 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases activity |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
|
multiple interactions |
ISO |
5 |
8,798,147 |
8,866,314 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
|
increases expression |
ISO |
5 |
8,798,147 |
8,866,314 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
|
increases expression |
ISO |
5 |
8,798,147 |
8,866,314 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
|
increases expression |
ISO |
5 |
8,893,721 |
8,959,226 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
decreases expression |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases activity |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
affects expression |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
decreases expression |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
11 |
94,204,609 |
94,254,290 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
|
affects expression |
ISO |
7 |
53,231,750 |
53,285,656 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
|
decreases expression |
ISO |
7 |
53,231,750 |
53,285,656 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
multiple interactions |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abhd1 |
abhydrolase domain containing 1 |
|
increases expression |
ISO |
5 |
31,252,439 |
31,257,468 |
RGD:6480464 |
CTD |
| G |
Abhd1 |
abhydrolase domain containing 1 |
|
multiple interactions |
ISO |
5 |
31,252,439 |
31,257,468 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
|
decreases expression |
ISO |
3 |
153,585,323 |
153,607,396 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
7 |
86,198,369 |
86,259,985 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
7 |
86,198,369 |
86,259,985 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
ISO |
11 |
105,829,261 |
105,851,259 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
ISO |
11 |
105,829,261 |
105,851,259 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
decreases expression |
ISO |
11 |
100,337,670 |
100,389,215 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases expression |
ISO |
15 |
81,702,893 |
81,745,567 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
ISO |
15 |
81,702,893 |
81,745,567 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
decreases expression |
ISO |
4 |
151,552,209 |
151,645,964 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
|
decreases expression |
ISO |
11 |
116,033,202 |
116,060,359 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
ISO |
9 |
21,931,171 |
21,940,190 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
EXP |
8 |
47,556,396 |
47,621,404 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
ISO |
8 |
47,556,396 |
47,621,404 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions |
EXP |
X |
138,752,536 |
138,825,078 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
increases expression |
ISO |
X |
138,752,536 |
138,825,078 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions |
ISO |
X |
138,752,536 |
138,825,078 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
EXP |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
decreases expression |
ISO |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
multiple interactions |
EXP |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
multiple interactions |
EXP |
2 |
113,873,025 |
113,878,547 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
EXP |
6 |
83,462,903 |
83,486,245 |
RGD:6480464 |
CTD |
| G |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
|
multiple interactions |
EXP |
7 |
141,074,882 |
141,416,780 |
RGD:6480464 |
CTD |
| G |
Adam17 |
a disintegrin and metallopeptidase domain 17 |
|
decreases expression |
ISO |
12 |
21,329,370 |
21,379,452 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
|
multiple interactions |
EXP |
16 |
85,794,072 |
85,803,360 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases expression |
ISO |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
ISO |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
multiple interactions |
EXP |
7 |
117,771,183 |
117,773,333 |
RGD:6480464 |
CTD |
| G |
Adora3 |
adenosine A3 receptor |
|
increases expression |
ISO |
3 |
105,673,776 |
105,726,960 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenergic receptor, alpha 1b |
|
increases expression |
ISO |
11 |
43,588,108 |
43,649,834 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenergic receptor, alpha 1d |
|
increases expression |
ISO |
2 |
131,371,093 |
131,388,021 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
increases expression |
ISO |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
multiple interactions |
ISO |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
multiple interactions |
EXP |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenergic receptor, beta 3 |
|
decreases expression |
EXP |
8 |
28,336,248 |
28,340,060 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 (Xenopus laevis) |
|
multiple interactions |
ISO |
12 |
36,719,512 |
36,730,668 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
decreases expression |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
decreases expression |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
EXP |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
EXP |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
increases expression |
EXP |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ahsa1 |
AHA1, activator of heat shock protein ATPase 1 |
|
increases expression |
EXP |
12 |
88,607,678 |
88,614,902 |
RGD:6480464 |
CTD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
increases response to substance |
ISO |
16 |
22,892,115 |
22,899,511 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
EXP |
X |
45,828,121 |
45,866,603 |
RGD:6480464 |
CTD |
| G |
Aim1 |
absent in melanoma 1 |
|
increases expression |
ISO |
10 |
43,670,113 |
43,724,652 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
|
multiple interactions |
EXP |
10 |
5,987,070 |
6,080,212 |
RGD:6480464 |
CTD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
multiple interactions |
ISO |
10 |
24,888,896 |
25,018,969 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
decreases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
decreases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases secretion |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
|
affects expression |
ISO |
19 |
20,676,472 |
20,717,952 |
RGD:6480464 |
CTD |
| G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
affects expression |
ISO |
4 |
45,811,894 |
45,817,480 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
ISO |
7 |
133,938,748 |
133,943,961 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
6 |
116,360,089 |
116,411,196 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
EXP |
4 |
137,297,647 |
137,352,292 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
increases expression |
ISO |
7 |
117,916,118 |
117,955,909 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
multiple interactions |
ISO |
7 |
117,916,118 |
117,955,909 |
RGD:6480464 |
CTD |
| G |
Amy1 |
amylase 1, salivary |
|
increases expression |
EXP |
3 |
113,258,870 |
113,280,668 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
multiple interactions |
ISO |
15 |
42,256,269 |
42,508,341 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
EXP |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
affects response to substance |
EXP |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
multiple interactions |
EXP |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
multiple interactions |
ISO |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Ank1 |
ankyrin 1, erythroid |
|
decreases expression |
ISO |
8 |
24,085,354 |
24,260,968 |
RGD:6480464 |
CTD |
| G |
Ank1 |
ankyrin 1, erythroid |
|
multiple interactions |
ISO |
8 |
24,085,354 |
24,260,968 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases expression |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases localization |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases phosphorylation |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
affects response to substance |
EXP |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
EXP |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
affects response to substance |
ISO |
19 |
20,447,924 |
20,465,161 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
EXP |
5 |
97,222,404 |
97,274,987 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
multiple interactions |
EXP |
11 |
54,792,464 |
54,846,973 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
multiple interactions |
ISO |
14 |
34,899,176 |
34,913,757 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
ISO |
1 |
58,086,813 |
58,163,254 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
increases expression |
ISO |
1 |
58,086,813 |
58,163,254 |
RGD:6480464 |
CTD |
| G |
Ap1g2 |
adaptor protein complex AP-1, gamma 2 subunit |
|
increases expression |
ISO |
14 |
55,717,687 |
55,725,430 |
RGD:6480464 |
CTD |
| G |
Apcdd1 |
adenomatosis polyposis coli down-regulated 1 |
|
multiple interactions |
EXP |
18 |
63,081,981 |
63,112,849 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
decreases expression |
ISO |
X |
45,378,323 |
45,388,029 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
multiple interactions |
ISO |
X |
45,378,323 |
45,388,029 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
affects expression |
ISO |
9 |
46,036,713 |
46,038,549 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
affects expression |
ISO |
9 |
46,048,927 |
46,051,541 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
ISO |
12 |
7,984,483 |
8,023,645 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
increases expression |
EXP |
9 |
46,041,134 |
46,043,380 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
multiple interactions |
EXP |
9 |
46,041,134 |
46,043,380 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
increases expression |
ISO |
9 |
46,041,134 |
46,043,380 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
multiple interactions |
ISO |
9 |
46,041,134 |
46,043,380 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
increases expression |
ISO |
4 |
40,980,107 |
40,995,169 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects activity |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
multiple interactions |
ISO |
X |
20,425,669 |
20,437,647 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
decreases expression |
ISO |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
increases expression |
ISO |
12 |
80,231,775 |
80,257,288 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
multiple interactions |
ISO |
12 |
80,231,775 |
80,257,288 |
RGD:6480464 |
CTD |
| G |
Arhgap10 |
Rho GTPase activating protein 10 |
|
increases expression |
EXP |
8 |
79,774,265 |
80,041,806 |
RGD:6480464 |
CTD |
| G |
Arhgap30 |
Rho GTPase activating protein 30 |
|
increases expression |
EXP |
1 |
173,319,091 |
173,340,371 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
multiple interactions |
EXP |
12 |
53,617,064 |
53,668,839 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
increases expression |
ISO |
3 |
95,238,312 |
95,301,162 |
RGD:6480464 |
CTD |
| G |
Art1 |
ADP-ribosyltransferase 1 |
|
multiple interactions |
ISO |
7 |
109,250,257 |
109,259,662 |
RGD:6480464 |
CTD |
| G |
Art1 |
ADP-ribosyltransferase 1 |
|
increases expression |
ISO |
7 |
109,250,257 |
109,259,662 |
RGD:6480464 |
CTD |
| G |
Art5 |
ADP-ribosyltransferase 5 |
|
increases expression |
ISO |
7 |
109,245,393 |
109,248,743 |
RGD:6480464 |
CTD |
| G |
Art5 |
ADP-ribosyltransferase 5 |
|
multiple interactions |
ISO |
7 |
109,245,393 |
109,248,743 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
|
decreases expression |
ISO |
19 |
32,059,136 |
32,177,630 |
RGD:6480464 |
CTD |
| G |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
|
multiple interactions |
ISO |
19 |
32,059,136 |
32,177,630 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthetase 1 |
|
increases expression |
ISO |
2 |
31,325,790 |
31,376,190 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthetase 1 |
|
multiple interactions |
ISO |
2 |
31,325,790 |
31,376,190 |
RGD:6480464 |
CTD |
| G |
Atcay |
ataxia, cerebellar, Cayman type homolog (human) |
|
decreases expression |
ISO |
10 |
80,667,258 |
80,693,524 |
RGD:6480464 |
CTD |
| G |
Atcay |
ataxia, cerebellar, Cayman type homolog (human) |
|
multiple interactions |
ISO |
10 |
80,667,258 |
80,693,524 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
increases expression |
ISO |
7 |
133,589,374 |
133,606,587 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases activity |
ISO |
2 |
130,406,413 |
130,408,277 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
decreases expression |
ISO |
2 |
121,973,423 |
121,978,818 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
decreases expression |
ISO |
18 |
20,843,100 |
20,904,905 |
RGD:6480464 |
CTD |
| G |
B4galt6 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 |
|
multiple interactions |
ISO |
18 |
20,843,100 |
20,904,905 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
EXP |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bambi |
BMP and activin membrane-bound inhibitor |
|
decreases expression |
EXP |
18 |
3,507,955 |
3,516,402 |
RGD:6480464 |
CTD |
| G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
decreases expression |
ISO |
15 |
25,293,032 |
25,343,519 |
RGD:6480464 |
CTD |
| G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
|
multiple interactions |
ISO |
15 |
25,293,032 |
25,343,519 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
EXP |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
multiple interactions |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
increases expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases response to substance |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases response to substance |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
decreases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases stability |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases response to substance |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases phosphorylation |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
EXP |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
EXP |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases response to substance |
EXP |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B cell leukemia/lymphoma 3 |
|
decreases expression |
ISO |
7 |
20,393,811 |
20,408,104 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B cell leukemia/lymphoma 3 |
|
multiple interactions |
ISO |
7 |
20,393,811 |
20,408,104 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases expression |
ISO |
10 |
74,523,641 |
74,647,668 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
10 |
74,523,641 |
74,647,668 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma carboxyglutamate protein |
|
multiple interactions |
ISO |
3 |
88,187,417 |
88,188,386 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma carboxyglutamate protein |
|
multiple interactions |
ISO |
3 |
88,187,417 |
88,188,386 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
multiple interactions |
ISO |
6 |
145,811,257 |
145,813,860 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
decreases expression |
ISO |
6 |
145,811,257 |
145,813,860 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
9 |
7,818,226 |
7,835,255 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects expression |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
11 |
117,710,551 |
117,717,057 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
2 |
133,378,935 |
133,388,621 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
2 |
133,378,935 |
133,388,621 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
affects expression |
EXP |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
EXP |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
multiple interactions |
ISO |
13 |
38,437,585 |
38,591,597 |
RGD:6480464 |
CTD |
| G |
Bmp8a |
bone morphogenetic protein 8a |
|
increases expression |
EXP |
4 |
122,989,888 |
123,020,046 |
RGD:6480464 |
CTD |
| G |
Bmp8a |
bone morphogenetic protein 8a |
|
decreases response to substance |
EXP |
4 |
122,989,888 |
123,020,046 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B cell translocation gene 1, anti-proliferative |
|
increases expression |
ISO |
10 |
96,079,635 |
96,085,447 |
RGD:6480464 |
CTD |
| G |
Btg2 |
B cell translocation gene 2, anti-proliferative |
|
increases expression |
ISO |
1 |
135,971,442 |
135,975,732 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
ISO |
17 |
57,343,396 |
57,367,559 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
EXP |
5 |
15,440,509 |
15,880,329 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases expression |
ISO |
4 |
15,808,411 |
15,833,856 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
|
multiple interactions |
ISO |
7 |
121,774,992 |
121,779,871 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
|
decreases response to substance |
ISO |
7 |
121,774,992 |
121,779,871 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
multiple interactions |
EXP |
9 |
62,705,911 |
62,723,725 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
ISO |
6 |
29,298,119 |
29,326,675 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
decreases expression |
ISO |
18 |
33,098,695 |
33,355,421 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
multiple interactions |
ISO |
18 |
33,098,695 |
33,355,421 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2 |
|
increases expression |
ISO |
1 |
184,397,390 |
184,447,614 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2 |
|
multiple interactions |
ISO |
1 |
184,397,390 |
184,447,614 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
decreases expression |
ISO |
11 |
84,771,256 |
84,779,556 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
multiple interactions |
ISO |
11 |
84,771,256 |
84,779,556 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
9 |
5,298,517 |
5,307,281 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
decreases expression |
ISO |
6 |
42,215,038 |
42,232,495 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases cleavage |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
decreases expression |
EXP |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
EXP |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
EXP |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
|
increases expression |
EXP |
10 |
62,206,676 |
62,255,116 |
RGD:6480464 |
CTD |
| G |
Ccdc86 |
coiled-coil domain containing 86 |
|
decreases expression |
ISO |
19 |
11,015,971 |
11,023,756 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
decreases expression |
ISO |
7 |
112,574,334 |
112,584,852 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
multiple interactions |
ISO |
7 |
112,574,334 |
112,584,852 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
multiple interactions |
EXP |
8 |
97,334,353 |
97,335,936 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl26 |
chemokine (C-C motif) ligand 26 |
|
multiple interactions |
ISO |
5 |
136,036,318 |
136,039,439 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
EXP |
11 |
83,461,345 |
83,462,880 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
EXP |
11 |
81,859,214 |
81,861,027 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases degradation |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases ubiquitination |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
6 |
127,075,726 |
127,101,066 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
11 |
40,562,054 |
40,568,788 |
RGD:6480464 |
CTD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
decreases expression |
ISO |
9 |
123,936,703 |
123,946,421 |
RGD:6480464 |
CTD |
| G |
Ccr4 |
chemokine (C-C motif) receptor 4 |
|
increases expression |
ISO |
9 |
114,399,434 |
114,405,662 |
RGD:6480464 |
CTD |
| G |
Ccr9 |
chemokine (C-C motif) receptor 9 |
|
increases expression |
EXP |
9 |
123,676,329 |
123,692,575 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 antigen |
|
increases expression |
ISO |
18 |
36,884,721 |
36,886,308 |
RGD:6480464 |
CTD |
| G |
Cd163 |
CD163 antigen |
|
increases expression |
ISO |
6 |
124,254,669 |
124,280,545 |
RGD:6480464 |
CTD |
| G |
Cd24a |
CD24a antigen |
|
increases expression |
ISO |
10 |
43,298,975 |
43,304,071 |
RGD:6480464 |
CTD |
| G |
Cd24a |
CD24a antigen |
|
multiple interactions |
ISO |
10 |
43,298,975 |
43,304,071 |
RGD:6480464 |
CTD |
| G |
Cd28 |
CD28 antigen |
|
multiple interactions |
ISO |
1 |
60,803,232 |
60,830,203 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
increases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
affects expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
multiple interactions |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
increases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd4 |
CD4 antigen |
|
multiple interactions |
ISO |
6 |
124,814,711 |
124,838,227 |
RGD:6480464 |
CTD |
| G |
Cd4 |
CD4 antigen |
|
decreases expression |
ISO |
6 |
124,814,711 |
124,838,227 |
RGD:6480464 |
CTD |
| G |
Cd53 |
CD53 antigen |
|
increases expression |
ISO |
3 |
106,561,779 |
106,593,067 |
RGD:6480464 |
CTD |
| G |
Cd68 |
CD68 antigen |
|
increases expression |
ISO |
11 |
69,477,873 |
69,479,564 |
RGD:6480464 |
CTD |
| G |
Cd69 |
CD69 antigen |
|
increases expression |
ISO |
6 |
129,217,343 |
129,225,387 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
increases activity |
EXP |
4 |
137,894,443 |
137,923,870 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 |
|
multiple interactions |
EXP |
4 |
136,875,611 |
136,913,652 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
decreases expression |
ISO |
2 |
72,314,276 |
72,324,947 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
multiple interactions |
ISO |
2 |
72,314,276 |
72,324,947 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
EXP |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
decreases expression |
ISO |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
ISO |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
multiple interactions |
ISO |
14 |
47,380,216 |
47,391,200 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
ISO |
14 |
47,380,216 |
47,391,200 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase 1, cytosolic |
|
multiple interactions |
EXP |
18 |
46,872,859 |
46,887,996 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
|
increases expression |
ISO |
7 |
26,246,721 |
26,262,644 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
EXP |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
multiple interactions |
EXP |
2 |
6,460,740 |
7,317,825 |
RGD:6480464 |
CTD |
| G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) |
|
decreases expression |
ISO |
9 |
108,728,651 |
108,755,300 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
decreases expression |
ISO |
8 |
95,689,971 |
95,721,703 |
RGD:6480464 |
CTD |
| G |
Ces1g |
carboxylesterase 1G |
|
increases expression |
ISO |
8 |
95,826,268 |
95,861,108 |
RGD:6480464 |
CTD |
| G |
Ces1g |
carboxylesterase 1G |
|
decreases expression |
ISO |
8 |
95,826,268 |
95,861,108 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
affects expression |
ISO |
8 |
107,524,753 |
107,544,310 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases expression |
ISO |
8 |
107,524,753 |
107,544,310 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
multiple interactions |
ISO |
8 |
107,524,753 |
107,544,310 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
decreases expression |
ISO |
8 |
107,524,753 |
107,544,310 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases expression |
ISO |
8 |
107,524,753 |
107,544,310 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
decreases expression |
EXP |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
ISO |
1 |
58,770,130 |
58,815,728 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
1 |
58,770,130 |
58,815,728 |
RGD:6480464 |
CTD |
| G |
Chi3l1 |
chitinase 3-like 1 |
|
decreases expression |
ISO |
1 |
136,078,981 |
136,086,608 |
RGD:6480464 |
CTD |
| G |
Chid1 |
chitinase domain containing 1 |
|
multiple interactions |
ISO |
7 |
148,679,035 |
148,725,756 |
RGD:6480464 |
CTD |
| G |
Chid1 |
chitinase domain containing 1 |
|
increases expression |
ISO |
7 |
148,679,035 |
148,725,756 |
RGD:6480464 |
CTD |
| G |
Chrnd |
cholinergic receptor, nicotinic, delta polypeptide |
|
increases expression |
ISO |
1 |
89,087,227 |
89,096,645 |
RGD:6480464 |
CTD |
| G |
Chrnd |
cholinergic receptor, nicotinic, delta polypeptide |
|
multiple interactions |
ISO |
1 |
89,087,227 |
89,096,645 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
19 |
44,147,824 |
44,181,967 |
RGD:6480464 |
CTD |
| G |
Cib2 |
calcium and integrin binding family member 2 |
|
multiple interactions |
ISO |
9 |
54,393,159 |
54,407,886 |
RGD:6480464 |
CTD |
| G |
Cib2 |
calcium and integrin binding family member 2 |
|
decreases expression |
ISO |
9 |
54,393,159 |
54,407,886 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
|
increases expression |
ISO |
18 |
67,503,218 |
67,527,448 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
|
multiple interactions |
ISO |
18 |
67,503,218 |
67,527,448 |
RGD:6480464 |
CTD |
| G |
Cirbp |
cold inducible RNA binding protein |
|
decreases expression |
EXP |
10 |
79,630,586 |
79,634,398 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
10 |
17,443,034 |
17,445,480 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Clcn4-2 |
chloride channel 4-2 |
|
decreases expression |
ISO |
7 |
7,235,027 |
7,252,222 |
RGD:6480464 |
CTD |
| G |
Clec3b |
C-type lectin domain family 3, member b |
|
multiple interactions |
EXP |
9 |
123,060,064 |
123,066,550 |
RGD:6480464 |
CTD |
| G |
Clic3 |
chloride intracellular channel 3 |
|
multiple interactions |
ISO |
2 |
25,312,363 |
25,314,292 |
RGD:6480464 |
CTD |
| G |
Cln6 |
ceroid-lipofuscinosis, neuronal 6 |
|
decreases expression |
ISO |
9 |
62,686,594 |
62,699,809 |
RGD:6480464 |
CTD |
| G |
Cln6 |
ceroid-lipofuscinosis, neuronal 6 |
|
multiple interactions |
ISO |
9 |
62,686,594 |
62,699,809 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
decreases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Cnksr1 |
connector enhancer of kinase suppressor of Ras 1 |
|
increases expression |
ISO |
4 |
133,783,957 |
133,794,314 |
RGD:6480464 |
CTD |
| G |
Cnksr1 |
connector enhancer of kinase suppressor of Ras 1 |
|
multiple interactions |
ISO |
4 |
133,783,957 |
133,794,314 |
RGD:6480464 |
CTD |
| G |
Cnn2 |
calponin 2 |
|
multiple interactions |
EXP |
10 |
79,451,345 |
79,458,145 |
RGD:6480464 |
CTD |
| G |
Cntn1 |
contactin 1 |
|
decreases expression |
ISO |
15 |
91,881,596 |
92,172,398 |
RGD:6480464 |
CTD |
| G |
Cntn1 |
contactin 1 |
|
multiple interactions |
ISO |
15 |
91,881,596 |
92,172,398 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
multiple interactions |
EXP |
3 |
113,733,458 |
113,923,244 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
multiple interactions |
ISO |
4 |
47,220,884 |
47,326,037 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
multiple interactions |
ISO |
4 |
47,220,884 |
47,326,037 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
decreases expression |
ISO |
4 |
47,220,884 |
47,326,037 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
15 |
97,806,033 |
97,835,155 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
affects expression |
EXP |
15 |
97,806,033 |
97,835,155 |
RGD:6480464 |
CTD |
| G |
Col3a1 |
collagen, type III, alpha 1 |
|
decreases expression |
ISO |
1 |
45,368,383 |
45,406,551 |
RGD:6480464 |
CTD |
| G |
Col3a1 |
collagen, type III, alpha 1 |
|
multiple interactions |
ISO |
1 |
45,368,383 |
45,406,551 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
multiple interactions |
EXP |
8 |
11,198,423 |
11,312,826 |
RGD:6480464 |
CTD |
| G |
Col4a6 |
collagen, type IV, alpha 6 |
|
multiple interactions |
ISO |
X |
137,599,946 |
137,908,619 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
decreases expression |
ISO |
2 |
27,741,945 |
27,895,030 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
multiple interactions |
ISO |
2 |
27,741,945 |
27,895,030 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
decreases expression |
ISO |
1 |
45,431,176 |
45,560,127 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
multiple interactions |
ISO |
1 |
45,431,176 |
45,560,127 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
multiple interactions |
ISO |
9 |
20,574,494 |
20,619,478 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
decreases expression |
ISO |
9 |
20,574,494 |
20,619,478 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
multiple interactions |
EXP |
1 |
92,663,435 |
92,740,514 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
decreases expression |
ISO |
1 |
92,663,435 |
92,740,514 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
multiple interactions |
ISO |
1 |
92,663,435 |
92,740,514 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
multiple interactions |
ISO |
9 |
108,855,790 |
108,886,920 |
RGD:6480464 |
CTD |
| G |
Col9a1 |
collagen, type IX, alpha 1 |
|
affects expression |
EXP |
1 |
24,184,449 |
24,259,577 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
ISO |
16 |
18,406,975 |
18,426,809 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
ISO |
16 |
18,406,975 |
18,426,809 |
RGD:6480464 |
CTD |
| G |
Copb2 |
coatomer protein complex, subunit beta 2 (beta prime) |
|
multiple interactions |
ISO |
9 |
98,464,150 |
98,488,794 |
RGD:6480464 |
CTD |
| G |
Copb2 |
coatomer protein complex, subunit beta 2 (beta prime) |
|
decreases expression |
ISO |
9 |
98,464,150 |
98,488,794 |
RGD:6480464 |
CTD |
| G |
COX1 |
cytochrome c oxidase I, mitochondrial |
|
increases expression |
ISO |
MT |
5,328 |
6,872 |
RGD:6480464 |
CTD |
| G |
COX2 |
cytochrome c oxidase II, mitochondrial |
|
increases expression |
ISO |
MT |
7,013 |
7,696 |
RGD:6480464 |
CTD |
| G |
COX3 |
cytochrome c oxidase III, mitochondrial |
|
increases expression |
ISO |
MT |
8,607 |
9,390 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin |
|
multiple interactions |
EXP |
3 |
19,857,054 |
19,907,609 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin |
|
increases expression |
ISO |
3 |
19,857,054 |
19,907,609 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin |
|
multiple interactions |
ISO |
3 |
19,857,054 |
19,907,609 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1, pancreatic |
|
decreases expression |
ISO |
6 |
30,589,221 |
30,595,361 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1, pancreatic |
|
multiple interactions |
ISO |
6 |
30,589,221 |
30,595,361 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
decreases expression |
ISO |
8 |
67,071,339 |
67,171,837 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
multiple interactions |
ISO |
8 |
67,071,339 |
67,171,837 |
RGD:6480464 |
CTD |
| G |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
|
increases expression |
ISO |
19 |
44,030,797 |
44,061,010 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
increases expression |
EXP |
1 |
67,169,640 |
67,277,022 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
increases expression |
ISO |
1 |
67,169,640 |
67,277,022 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein II |
|
decreases expression |
EXP |
3 |
87,752,615 |
87,757,294 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases expression |
ISO |
3 |
19,593,401 |
19,595,396 |
RGD:6480464 |
CTD |
| G |
Crisp4 |
cysteine-rich secretory protein 4 |
|
decreases expression |
ISO |
1 |
18,105,272 |
18,127,132 |
RGD:6480464 |
CTD |
| G |
Crisp4 |
cysteine-rich secretory protein 4 |
|
multiple interactions |
ISO |
1 |
18,105,272 |
18,127,132 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
EXP |
16 |
17,452,080 |
17,486,348 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
ISO |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
multiple interactions |
ISO |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
3 |
107,543,966 |
107,563,387 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
increases expression |
ISO |
18 |
61,265,226 |
61,290,793 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
11 |
98,562,627 |
98,564,943 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 |
|
increases expression |
ISO |
7 |
56,085,768 |
56,099,021 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 |
|
multiple interactions |
ISO |
7 |
56,085,768 |
56,099,021 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
multiple interactions |
ISO |
19 |
5,344,705 |
5,349,574 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
EXP |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctsl |
cathepsin L |
|
increases expression |
ISO |
13 |
64,464,522 |
64,471,614 |
RGD:6480464 |
CTD |
| G |
Ctsl |
cathepsin L |
|
increases expression |
ISO |
13 |
64,464,522 |
64,471,614 |
RGD:6480464 |
CTD |
| G |
Ctsl |
cathepsin L |
|
multiple interactions |
ISO |
13 |
64,464,522 |
64,471,614 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
EXP |
8 |
97,296,080 |
97,306,327 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
multiple interactions |
ISO |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
multiple interactions |
ISO |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
multiple interactions |
EXP |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
multiple interactions |
EXP |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
6 |
117,118,553 |
117,131,386 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
EXP |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
decreases expression |
EXP |
1 |
92,100,578 |
92,112,863 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
decreases expression |
ISO |
15 |
82,983,931 |
83,002,638 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
9,012,378 |
9,046,450 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
6 |
50,512,562 |
50,516,473 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
affects activity |
EXP |
2 |
170,308,465 |
170,322,638 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
2 |
170,308,465 |
170,322,638 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
2 |
170,308,465 |
170,322,638 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
74,760,148 |
74,784,464 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
74,760,148 |
74,784,464 |
RGD:6480464 |
CTD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
10 |
126,485,302 |
126,490,062 |
RGD:6480464 |
CTD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
affects activity |
EXP |
10 |
126,485,302 |
126,490,062 |
RGD:6480464 |
CTD |
| G |
Cyp2a12 |
cytochrome P450, family 2, subfamily a, polypeptide 12 |
|
affects expression |
ISO |
7 |
27,814,109 |
27,821,837 |
RGD:6480464 |
CTD |
| G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
|
multiple interactions |
ISO |
7 |
27,092,211 |
27,100,107 |
RGD:6480464 |
CTD |
| G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
|
increases activity |
ISO |
7 |
27,092,211 |
27,100,107 |
RGD:6480464 |
CTD |
| G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
|
increases expression |
ISO |
7 |
27,092,211 |
27,100,107 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
multiple interactions |
ISO |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
increases expression |
ISO |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
|
increases expression |
EXP |
7 |
26,682,683 |
26,711,643 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
increases expression |
ISO |
7 |
26,846,514 |
26,881,215 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
affects expression |
ISO |
7 |
26,846,514 |
26,881,215 |
RGD:6480464 |
CTD |
| G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
|
affects expression |
ISO |
19 |
39,464,046 |
39,537,565 |
RGD:6480464 |
CTD |
| G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
|
affects binding |
ISO |
19 |
39,188,388 |
39,261,246 |
RGD:6480464 |
CTD |
| G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
|
increases expression |
ISO |
19 |
39,188,388 |
39,261,246 |
RGD:6480464 |
CTD |
| G |
Cyp2d9 |
cytochrome P450, family 2, subfamily d, polypeptide 9 |
|
increases expression |
ISO |
15 |
82,282,807 |
82,287,257 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
|
multiple interactions |
EXP |
5 |
146,666,183 |
146,691,430 |
RGD:6480464 |
CTD |
| G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
|
increases expression |
EXP |
5 |
146,666,183 |
146,691,430 |
RGD:6480464 |
CTD |
| G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
|
increases expression |
EXP |
5 |
138,334,161 |
138,362,847 |
RGD:6480464 |
CTD |
| G |
Cyp3a16 |
cytochrome P450, family 3, subfamily a, polypeptide 16 |
|
increases expression |
EXP |
5 |
146,197,178 |
146,230,592 |
RGD:6480464 |
CTD |
| G |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
|
affects expression |
ISO |
5 |
146,788,770 |
146,821,194 |
RGD:6480464 |
CTD |
| G |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
|
increases expression |
ISO |
5 |
146,788,770 |
146,821,194 |
RGD:6480464 |
CTD |
| G |
Cyp3a25 |
cytochrome P450, family 3, subfamily a, polypeptide 25 |
|
increases expression |
EXP |
5 |
146,788,770 |
146,821,194 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
affects expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
affects metabolic processing |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases activity |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
multiple interactions |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
increases expression |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
Cyp3a44 |
cytochrome P450, family 3, subfamily a, polypeptide 44 |
|
increases expression |
EXP |
5 |
146,585,559 |
146,617,450 |
RGD:6480464 |
CTD |
| G |
Cyp4a14 |
cytochrome P450, family 4, subfamily a, polypeptide 14 |
|
increases expression |
EXP |
4 |
115,158,805 |
115,168,746 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
decreases expression |
EXP |
5 |
4,080,674 |
4,104,697 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
affects expression |
ISO |
5 |
4,080,674 |
4,104,697 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
4 |
6,192,759 |
6,202,778 |
RGD:6480464 |
CTD |
| G |
D14Abb1e |
DNA segment, Chr 14, Abbott 1 expressed |
|
increases expression |
EXP |
14 |
28,242,033 |
28,296,741 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta hydroxylase |
|
multiple interactions |
ISO |
2 |
27,021,027 |
27,038,724 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta hydroxylase |
|
increases expression |
ISO |
2 |
27,021,027 |
27,038,724 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta hydroxylase |
|
multiple interactions |
ISO |
2 |
27,021,027 |
27,038,724 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta hydroxylase |
|
decreases expression |
ISO |
2 |
27,021,027 |
27,038,724 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site albumin promoter binding protein |
|
decreases expression |
ISO |
7 |
52,960,617 |
52,965,573 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site albumin promoter binding protein |
|
increases expression |
ISO |
7 |
52,960,617 |
52,965,573 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
multiple interactions |
EXP |
10 |
96,942,134 |
96,980,796 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
EXP |
10 |
59,412,423 |
59,414,518 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
multiple interactions |
ISO |
10 |
59,412,423 |
59,414,518 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
10 |
59,412,423 |
59,414,518 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
increases expression |
ISO |
4 |
15,844,387 |
15,872,654 |
RGD:6480464 |
CTD |
| G |
Degs1 |
degenerative spermatocyte homolog 1 (Drosophila) |
|
decreases expression |
ISO |
1 |
184,205,901 |
184,212,890 |
RGD:6480464 |
CTD |
| G |
Degs1 |
degenerative spermatocyte homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
1 |
184,205,901 |
184,212,890 |
RGD:6480464 |
CTD |
| G |
Dfna5 |
deafness, autosomal dominant 5 (human) |
|
increases expression |
ISO |
6 |
50,157,402 |
50,211,768 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
multiple interactions |
EXP |
15 |
76,332,445 |
76,342,248 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
increases expression |
ISO |
7 |
106,302,173 |
106,331,223 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
multiple interactions |
ISO |
7 |
106,302,173 |
106,331,223 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo homolog (Drosophila) |
|
affects localization |
ISO |
5 |
123,961,339 |
123,974,173 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo homolog (Drosophila) |
|
multiple interactions |
ISO |
5 |
123,961,339 |
123,974,173 |
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine type III |
|
decreases activity |
ISO |
12 |
111,517,440 |
111,519,307 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
increases expression |
EXP |
4 |
40,669,501 |
40,684,186 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
multiple interactions |
EXP |
12 |
45,306,884 |
45,311,055 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
EXP |
12 |
45,306,884 |
45,311,055 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
17 |
26,642,536 |
26,645,417 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
17 |
26,642,536 |
26,645,417 |
RGD:6480464 |
CTD |
| G |
Dusp28 |
dual specificity phosphatase 28 |
|
increases expression |
EXP |
1 |
94,803,566 |
94,805,197 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
ISO |
14 |
104,213,842 |
104,243,390 |
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
increases expression |
ISO |
2 |
180,882,397 |
180,891,720 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
8 |
28,370,799 |
28,386,128 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
8 |
28,370,799 |
28,386,128 |
RGD:6480464 |
CTD |
| G |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
|
increases expression |
ISO |
4 |
137,549,385 |
137,762,398 |
RGD:6480464 |
CTD |
| G |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
|
multiple interactions |
ISO |
4 |
137,549,385 |
137,762,398 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
|
multiple interactions |
EXP |
19 |
46,206,389 |
46,210,184 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
|
multiple interactions |
EXP |
3 |
129,235,304 |
129,341,413 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
multiple interactions |
EXP |
13 |
118,009,380 |
118,063,222 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
multiple interactions |
EXP |
6 |
135,312,949 |
135,333,191 |
RGD:6480464 |
CTD |
| G |
Emp2 |
epithelial membrane protein 2 |
|
multiple interactions |
ISO |
16 |
10,281,842 |
10,314,061 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
decreases expression |
ISO |
9 |
14,158,434 |
14,185,686 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
multiple interactions |
EXP |
15 |
54,670,453 |
54,751,701 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
15 |
81,416,644 |
81,482,507 |
RGD:6480464 |
CTD |
| G |
Epha7 |
Eph receptor A7 |
|
multiple interactions |
ISO |
4 |
28,740,295 |
28,894,649 |
RGD:6480464 |
CTD |
| G |
Epha7 |
Eph receptor A7 |
|
decreases expression |
ISO |
4 |
28,740,295 |
28,894,649 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
EXP |
14 |
66,703,214 |
66,743,337 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
increases expression |
ISO |
14 |
66,703,214 |
66,743,337 |
RGD:6480464 |
CTD |
| G |
Ereg |
epiregulin |
|
increases expression |
ISO |
5 |
91,503,643 |
91,522,675 |
RGD:6480464 |
CTD |
| G |
Erp29 |
endoplasmic reticulum protein 29 |
|
decreases expression |
ISO |
5 |
121,894,762 |
121,902,483 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
4 |
150,229,200 |
150,242,989 |
RGD:6480464 |
CTD |
| G |
Espl1 |
extra spindle poles-like 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
15 |
102,126,724 |
102,154,787 |
RGD:6480464 |
CTD |
| G |
Espl1 |
extra spindle poles-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
15 |
102,126,724 |
102,154,787 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
|
decreases expression |
ISO |
9 |
32,503,627 |
32,565,405 |
RGD:6480464 |
CTD |
| G |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
|
increases expression |
ISO |
16 |
95,924,014 |
95,942,656 |
RGD:6480464 |
CTD |
| G |
Evl |
Ena-vasodilator stimulated phosphoprotein |
|
multiple interactions |
ISO |
12 |
109,792,930 |
109,926,726 |
RGD:6480464 |
CTD |
| G |
Evl |
Ena-vasodilator stimulated phosphoprotein |
|
decreases expression |
ISO |
12 |
109,792,930 |
109,926,726 |
RGD:6480464 |
CTD |
| G |
Exoc2 |
exocyst complex component 2 |
|
decreases expression |
ISO |
13 |
30,905,787 |
31,065,916 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
2 |
91,465,477 |
91,476,571 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
2 |
91,465,477 |
91,476,571 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
affects expression |
ISO |
2 |
91,465,477 |
91,476,571 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
affects expression |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
multiple interactions |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
multiple interactions |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
multiple interactions |
EXP |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III |
|
multiple interactions |
ISO |
3 |
121,426,455 |
121,437,970 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
ISO |
6 |
71,149,882 |
71,155,017 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
decreases expression |
ISO |
19 |
10,257,378 |
10,271,364 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
increases expression |
ISO |
7 |
91,733,669 |
91,754,452 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
multiple interactions |
ISO |
7 |
91,733,669 |
91,754,452 |
RGD:6480464 |
CTD |
| G |
Fam216a |
family with sequence similarity 216, member A |
|
decreases expression |
ISO |
5 |
122,814,593 |
122,821,972 |
RGD:6480464 |
CTD |
| G |
Fam65b |
family with sequence similarity 65, member B |
|
increases expression |
ISO |
13 |
24,706,479 |
24,825,675 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
increases expression |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
multiple interactions |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
multiple interactions |
EXP |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
decreases expression |
ISO |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
decreases secretion |
ISO |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fbn2 |
fibrillin 2 |
|
multiple interactions |
EXP |
18 |
58,168,277 |
58,369,580 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose bisphosphatase 2 |
|
decreases expression |
ISO |
13 |
62,938,245 |
62,959,730 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose bisphosphatase 2 |
|
multiple interactions |
ISO |
13 |
62,938,245 |
62,959,730 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
multiple interactions |
EXP |
15 |
58,011,634 |
58,046,433 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
increases expression |
EXP |
15 |
58,011,634 |
58,046,433 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
increases expression |
ISO |
15 |
58,011,634 |
58,046,433 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
multiple interactions |
ISO |
15 |
58,011,634 |
58,046,433 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
increases expression |
ISO |
14 |
63,763,987 |
63,796,630 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthetase |
|
multiple interactions |
EXP |
3 |
88,897,510 |
88,905,867 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
EXP |
9 |
51,751,412 |
51,771,638 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
decreases expression |
ISO |
9 |
51,751,412 |
51,771,638 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
ISO |
9 |
51,751,412 |
51,771,638 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
decreases expression |
ISO |
3 |
82,846,225 |
82,853,712 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
ISO |
3 |
37,247,575 |
37,303,752 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
EXP |
2 |
125,860,394 |
125,916,921 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
EXP |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases response to substance |
EXP |
5 |
34,064,373 |
34,079,713 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
ISO |
X |
53,984,964 |
54,046,523 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
multiple interactions |
EXP |
X |
160,811,480 |
160,840,579 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
increases expression |
EXP |
6 |
128,380,125 |
128,388,649 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
multiple interactions |
EXP |
6 |
128,380,125 |
128,388,649 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
increases expression |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
EXP |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
increases expression |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
increases expression |
ISO |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Flot1 |
flotillin 1 |
|
multiple interactions |
ISO |
17 |
35,960,302 |
35,969,732 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
affects expression |
ISO |
1 |
164,759,692 |
164,796,679 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
1 |
164,759,692 |
164,796,679 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
multiple interactions |
EXP |
1 |
164,883,931 |
164,914,622 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
increases expression |
EXP |
5 |
32,438,845 |
32,460,213 |
RGD:6480464 |
CTD |
| G |
Foxg1 |
forkhead box G1 |
|
decreases expression |
ISO |
12 |
50,483,870 |
50,487,854 |
RGD:6480464 |
CTD |
| G |
Foxg1 |
forkhead box G1 |
|
multiple interactions |
ISO |
12 |
50,483,870 |
50,487,854 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
increases expression |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
increases expression |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
multiple interactions |
ISO |
13 |
31,650,039 |
31,652,845 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
increases expression |
ISO |
17 |
18,013,435 |
18,020,903 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
multiple interactions |
ISO |
17 |
18,013,435 |
18,020,903 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
multiple interactions |
EXP |
5 |
143,722,034 |
143,734,868 |
RGD:6480464 |
CTD |
| G |
Gys1 |
glycogen synthase 1, muscle |
|
affects phosphorylation |
ISO |
7 |
52,690,209 |
52,711,987 |
RGD:6480464 |
CTD |
| G |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
|
increases expression |
ISO |
17 |
34,419,696 |
34,424,716 |
RGD:6480464 |
CTD |
| G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
affects expression |
ISO |
17 |
34,400,172 |
34,406,363 |
RGD:6480464 |
CTD |
| G |
H2-DMb1 |
histocompatibility 2, class II, locus Mb1 |
|
decreases expression |
ISO |
17 |
34,290,136 |
34,297,174 |
RGD:6480464 |
CTD |
| G |
H2-Ea-ps |
histocompatibility 2, class II antigen E alpha, pseudogene |
|
increases expression |
ISO |
17 |
34,478,902 |
34,484,492 |
RGD:6480464 |
CTD |
| G |
Hao1 |
hydroxyacid oxidase 1, liver |
|
multiple interactions |
ISO |
2 |
134,323,097 |
134,380,088 |
RGD:6480464 |
CTD |
| G |
Has2 |
hyaluronan synthase 2 |
|
decreases expression |
ISO |
15 |
56,497,182 |
56,526,101 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
decreases expression |
ISO |
18 |
36,664,581 |
36,675,459 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac4 |
histone deacetylase 4 |
|
increases expression |
ISO |
1 |
93,829,311 |
94,044,970 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
ISO |
2 |
126,419,404 |
126,444,401 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
ISO |
2 |
126,419,404 |
126,444,401 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
decreases activity |
ISO |
2 |
126,419,404 |
126,444,401 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
decreases expression |
ISO |
2 |
126,419,404 |
126,444,401 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
decreases expression |
ISO |
16 |
30,065,443 |
30,067,882 |
RGD:6480464 |
CTD |
| G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
|
increases expression |
ISO |
6 |
52,496,224 |
52,590,294 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
increases acetylation |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hist4h4 |
histone cluster 4, H4 |
|
multiple interactions |
ISO |
6 |
136,752,589 |
136,752,900 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
multiple interactions |
EXP |
6 |
82,675,019 |
82,724,448 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
decreases expression |
ISO |
6 |
82,675,019 |
82,724,448 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
decreases expression |
ISO |
8 |
59,990,640 |
59,994,796 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
multiple interactions |
EXP |
13 |
97,418,917 |
97,440,891 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
increases expression |
ISO |
13 |
97,418,917 |
97,440,891 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
multiple interactions |
EXP |
16 |
91,406,480 |
91,426,079 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
multiple interactions |
EXP |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12b |
|
multiple interactions |
ISO |
11 |
44,213,565 |
44,227,519 |
RGD:6480464 |
CTD |
| G |
Il12rb1 |
interleukin 12 receptor, beta 1 |
|
decreases expression |
ISO |
8 |
73,332,348 |
73,345,323 |
RGD:6480464 |
CTD |
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
decreases expression |
ISO |
6 |
67,242,012 |
67,326,131 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases expression |
EXP |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il15 |
interleukin 15 |
|
increases expression |
ISO |
8 |
84,855,523 |
84,926,444 |
RGD:6480464 |
CTD |
| G |
Il15 |
interleukin 15 |
|
decreases expression |
ISO |
8 |
84,855,523 |
84,926,444 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
2 |
129,125,346 |
129,135,708 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
EXP |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
EXP |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
multiple interactions |
ISO |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
|
decreases expression |
ISO |
16 |
91,729,616 |
91,920,824 |
RGD:6480464 |
CTD |
| G |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
|
multiple interactions |
ISO |
16 |
91,729,616 |
91,920,824 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
multiple interactions |
ISO |
2 |
136,907,194 |
136,942,067 |
RGD:6480464 |
CTD |
| G |
Jam3 |
junction adhesion molecule 3 |
|
increases expression |
ISO |
9 |
26,904,969 |
26,962,965 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
decreases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
|
multiple interactions |
ISO |
3 |
106,904,485 |
106,909,797 |
RGD:6480464 |
CTD |
| G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
increases expression |
ISO |
6 |
126,482,569 |
126,485,573 |
RGD:6480464 |
CTD |
| G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
multiple interactions |
ISO |
6 |
126,482,569 |
126,485,573 |
RGD:6480464 |
CTD |
| G |
Kcnab1 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
|
decreases expression |
ISO |
3 |
64,913,565 |
65,182,141 |
RGD:6480464 |
CTD |
| G |
Kcnab1 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
|
multiple interactions |
ISO |
3 |
64,913,565 |
65,182,141 |
RGD:6480464 |
CTD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
multiple interactions |
ISO |
2 |
166,928,878 |
167,014,299 |
RGD:6480464 |
CTD |
| G |
Kcnk1 |
potassium channel, subfamily K, member 1 |
|
increases expression |
EXP |
8 |
128,519,002 |
128,554,585 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
multiple interactions |
ISO |
14 |
24,117,983 |
24,823,427 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
decreases expression |
ISO |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
multiple interactions |
ISO |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
multiple interactions |
ISO |
14 |
103,375,798 |
103,381,854 |
RGD:6480464 |
CTD |
| G |
Kif1a |
kinesin family member 1A |
|
multiple interactions |
ISO |
1 |
94,912,033 |
94,998,442 |
RGD:6480464 |
CTD |
| G |
Kif1a |
kinesin family member 1A |
|
decreases expression |
ISO |
1 |
94,912,033 |
94,998,442 |
RGD:6480464 |
CTD |
| G |
Kit |
kit oncogene |
|
decreases expression |
EXP |
5 |
75,971,012 |
76,052,747 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
multiple interactions |
EXP |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
EXP |
4 |
55,540,009 |
55,545,347 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
affects phosphorylation |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
multiple interactions |
EXP |
10 |
36,853,049 |
36,858,732 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
decreases expression |
ISO |
19 |
30,307,447 |
30,314,172 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
multiple interactions |
ISO |
19 |
30,307,447 |
30,314,172 |
RGD:6480464 |
CTD |
| G |
Mbnl1 |
muscleblind-like 1 (Drosophila) |
|
increases expression |
ISO |
3 |
60,305,174 |
60,433,670 |
RGD:6480464 |
CTD |
| G |
Mbnl1 |
muscleblind-like 1 (Drosophila) |
|
multiple interactions |
ISO |
3 |
60,305,174 |
60,433,670 |
RGD:6480464 |
CTD |
| G |
Mc5r |
melanocortin 5 receptor |
|
increases expression |
ISO |
18 |
68,497,257 |
68,499,365 |
RGD:6480464 |
CTD |
| G |
Mc5r |
melanocortin 5 receptor |
|
multiple interactions |
ISO |
18 |
68,497,257 |
68,499,365 |
RGD:6480464 |
CTD |
| G |
Mcam |
melanoma cell adhesion molecule |
|
decreases expression |
ISO |
9 |
43,942,741 |
43,950,809 |
RGD:6480464 |
CTD |
| G |
Mcam |
melanoma cell adhesion molecule |
|
multiple interactions |
ISO |
9 |
43,942,741 |
43,950,809 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases expression |
ISO |
3 |
95,462,643 |
95,467,102 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
3 |
95,462,643 |
95,467,102 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases expression |
ISO |
3 |
95,462,643 |
95,467,102 |
RGD:6480464 |
CTD |
| G |
Mcoln2 |
mucolipin 2 |
|
decreases expression |
ISO |
3 |
145,812,797 |
145,858,476 |
RGD:6480464 |
CTD |
| G |
Mcoln2 |
mucolipin 2 |
|
multiple interactions |
ISO |
3 |
145,812,797 |
145,858,476 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
multiple interactions |
ISO |
9 |
86,474,970 |
86,589,947 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
decreases expression |
ISO |
9 |
86,474,970 |
86,589,947 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
affects response to substance |
EXP |
11 |
98,013,468 |
98,054,607 |
RGD:6480464 |
CTD |
| G |
Mettl7a1 |
methyltransferase like 7A1 |
|
increases expression |
ISO |
15 |
100,135,248 |
100,144,779 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Nelfa |
negative elongation factor complex member A, Whsc2 |
|
increases expression |
ISO |
5 |
34,240,828 |
34,278,907 |
RGD:6480464 |
CTD |
| G |
Noc2l |
nucleolar complex associated 2 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Noc3l |
nucleolar complex associated 3 homolog (S. cerevisiae) |
|
increases expression |
EXP |
19 |
38,862,618 |
38,893,727 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
multiple interactions |
ISO |
8 |
107,800,347 |
107,805,839 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
increases expression |
ISO |
8 |
107,800,347 |
107,805,839 |
RGD:6480464 |
CTD |
| G |
Nop16 |
NOP16 nucleolar protein |
|
decreases expression |
ISO |
13 |
54,685,552 |
54,691,435 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
EXP |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
affects expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects response to substance |
EXP |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects localization |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases expression |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases activity |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases expression |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
increases expression |
ISO |
8 |
79,426,407 |
79,767,538 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
EXP |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
affects localization |
ISO |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr6a1 |
nuclear receptor subfamily 6, group A, member 1 |
|
increases expression |
ISO |
2 |
38,578,894 |
38,781,981 |
RGD:6480464 |
CTD |
| G |
Nrxn2 |
neurexin II |
|
multiple interactions |
ISO |
19 |
6,428,016 |
6,533,217 |
RGD:6480464 |
CTD |
| G |
Nrxn2 |
neurexin II |
|
increases expression |
ISO |
19 |
6,428,016 |
6,533,217 |
RGD:6480464 |
CTD |
| G |
Nudt21 |
nudix (nucleoside diphosphate linked moiety X)-type motif 21 |
|
increases expression |
EXP |
8 |
96,543,303 |
96,560,939 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase, structural 1 |
|
decreases expression |
ISO |
12 |
17,551,679 |
17,558,308 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase, structural 1 |
|
increases expression |
ISO |
12 |
17,551,679 |
17,558,308 |
RGD:6480464 |
CTD |
| G |
Ogn |
osteoglycin |
|
multiple interactions |
EXP |
13 |
49,703,440 |
49,719,869 |
RGD:6480464 |
CTD |
| G |
Olfm4 |
olfactomedin 4 |
|
increases expression |
ISO |
14 |
80,400,109 |
80,421,737 |
RGD:6480464 |
CTD |
| G |
Omd |
osteomodulin |
|
multiple interactions |
EXP |
13 |
49,678,116 |
49,687,978 |
RGD:6480464 |
CTD |
| G |
Onecut1 |
one cut domain, family member 1 |
|
increases expression |
ISO |
9 |
74,709,728 |
74,737,455 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
multiple interactions |
EXP |
4 |
63,005,600 |
63,009,196 |
RGD:6480464 |
CTD |
| G |
Orm2 |
orosomucoid 2 |
|
multiple interactions |
EXP |
4 |
63,023,483 |
63,026,911 |
RGD:6480464 |
CTD |
| G |
Orm3 |
orosomucoid 3 |
|
multiple interactions |
EXP |
4 |
63,017,196 |
63,020,545 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator activator receptor delta |
|
increases expression |
ISO |
17 |
28,369,699 |
28,438,414 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
decreases expression |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
increases expression |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
decreases expression |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
increases expression |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
5 |
51,845,488 |
51,945,160 |
RGD:6480464 |
CTD |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
decreases expression |
ISO |
5 |
77,342,274 |
77,380,603 |
RGD:6480464 |
CTD |
| G |
Ppib |
peptidylprolyl isomerase B |
|
increases expression |
ISO |
9 |
65,907,976 |
65,914,436 |
RGD:6480464 |
CTD |
| G |
Ppib |
peptidylprolyl isomerase B |
|
multiple interactions |
ISO |
9 |
65,907,976 |
65,914,436 |
RGD:6480464 |
CTD |
| G |
Ppp2r5a |
protein phosphatase 2, regulatory subunit B (B56), alpha isoform |
|
decreases expression |
EXP |
1 |
193,175,860 |
193,220,920 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isoform |
|
decreases expression |
ISO |
14 |
21,318,536 |
21,365,795 |
RGD:6480464 |
CTD |
| G |
Prim2 |
DNA primase, p58 subunit |
|
decreases expression |
ISO |
1 |
33,510,656 |
33,726,603 |
RGD:6480464 |
CTD |
| G |
Prim2 |
DNA primase, p58 subunit |
|
multiple interactions |
ISO |
1 |
33,510,656 |
33,726,603 |
RGD:6480464 |
CTD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
decreases phosphorylation |
ISO |
3 |
146,392,543 |
146,475,910 |
RGD:6480464 |
CTD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
multiple interactions |
ISO |
3 |
146,392,543 |
146,475,910 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor alpha |
|
multiple interactions |
EXP |
9 |
68,501,609 |
69,226,838 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor alpha |
|
increases expression |
ISO |
9 |
68,501,609 |
69,226,838 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
ISO |
2 |
27,532,721 |
27,618,839 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
|
increases expression |
ISO |
3 |
90,472,993 |
90,473,956 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
increases expression |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
decreases expression |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
increases expression |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 (calgranulin B) |
|
multiple interactions |
ISO |
3 |
90,496,555 |
90,499,613 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
ISO |
5 |
125,757,460 |
125,821,444 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
19 |
44,468,940 |
44,482,199 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
ISO |
19 |
44,468,940 |
44,482,199 |
RGD:6480464 |
CTD |
| G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
|
decreases expression |
ISO |
19 |
44,368,166 |
44,381,354 |
RGD:6480464 |
CTD |
| G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
|
affects expression |
ISO |
19 |
44,368,166 |
44,381,354 |
RGD:6480464 |
CTD |
| G |
Scel |
sciellin |
|
increases expression |
ISO |
14 |
103,912,558 |
104,012,563 |
RGD:6480464 |
CTD |
| G |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
|
decreases expression |
ISO |
15 |
100,701,114 |
100,876,360 |
RGD:6480464 |
CTD |
| G |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
|
multiple interactions |
ISO |
15 |
100,701,114 |
100,876,360 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
increases expression |
EXP |
6 |
125,271,358 |
125,294,961 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
multiple interactions |
ISO |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
increases expression |
ISO |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
increases expression |
EXP |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
increases expression |
ISO |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
|
multiple interactions |
ISO |
7 |
128,878,021 |
128,911,991 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
|
increases expression |
ISO |
7 |
128,878,021 |
128,911,991 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
|
increases expression |
ISO |
7 |
128,878,021 |
128,911,991 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
decreases expression |
ISO |
12 |
8,778,202 |
8,800,494 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
multiple interactions |
EXP |
15 |
32,850,478 |
32,964,476 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
increases expression |
ISO |
2 |
164,249,747 |
164,268,688 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
multiple interactions |
ISO |
2 |
164,249,747 |
164,268,688 |
RGD:6480464 |
CTD |
| G |
Sdcbp |
syndecan binding protein |
|
increases expression |
ISO |
4 |
6,292,827 |
6,323,269 |
RGD:6480464 |
CTD |
| G |
Sephs2 |
selenophosphate synthetase 2 |
|
increases expression |
ISO |
7 |
134,415,393 |
134,417,573 |
RGD:6480464 |
CTD |
| G |
Sephs2 |
selenophosphate synthetase 2 |
|
multiple interactions |
ISO |
7 |
134,415,393 |
134,417,573 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
increases expression |
ISO |
15 |
3,220,767 |
3,230,508 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
increases secretion |
ISO |
15 |
3,220,767 |
3,230,508 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
multiple interactions |
ISO |
15 |
3,220,767 |
3,230,508 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
increases expression |
ISO |
10 |
62,781,753 |
62,801,783 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
62,781,753 |
62,801,783 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases expression |
ISO |
11 |
76,812,099 |
76,845,845 |
RGD:6480464 |
CTD |
| G |
Slc7a6 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 |
|
multiple interactions |
ISO |
8 |
108,692,775 |
108,722,604 |
RGD:6480464 |
CTD |
| G |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
|
increases expression |
ISO |
13 |
74,258,963 |
74,303,512 |
RGD:6480464 |
CTD |
| G |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
|
increases expression |
ISO |
13 |
74,258,963 |
74,303,512 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
EXP |
6 |
141,855,802 |
141,895,483 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
ISO |
6 |
141,855,802 |
141,895,483 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
ISO |
6 |
141,855,802 |
141,895,483 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
ISO |
6 |
141,753,961 |
141,804,692 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
affects expression |
ISO |
6 |
141,753,961 |
141,804,692 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
ISO |
6 |
141,753,961 |
141,804,692 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
increases expression |
ISO |
6 |
141,753,961 |
141,804,692 |
RGD:6480464 |
CTD |
| G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
|
decreases expression |
EXP |
6 |
141,578,039 |
141,635,156 |
RGD:6480464 |
CTD |
| G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
|
decreases expression |
ISO |
6 |
141,578,039 |
141,635,156 |
RGD:6480464 |
CTD |
| G |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
|
multiple interactions |
ISO |
6 |
141,578,039 |
141,635,156 |
RGD:6480464 |
CTD |
| G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
decreases expression |
EXP |
9 |
102,910,819 |
102,990,179 |
RGD:6480464 |
CTD |
| G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
|
decreases expression |
EXP |
7 |
106,806,314 |
106,859,850 |
RGD:6480464 |
CTD |
| G |
Slco4c1 |
solute carrier organic anion transporter family, member 4C1 |
|
multiple interactions |
ISO |
1 |
98,715,361 |
98,768,748 |
RGD:6480464 |
CTD |
| G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
multiple interactions |
EXP |
2 |
164,179,806 |
164,182,243 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
affects expression |
EXP |
9 |
63,494,574 |
63,605,801 |
RGD:6480464 |
CTD |
| G |
Smoc2 |
SPARC related modular calcium binding 2 |
|
decreases expression |
ISO |
17 |
14,416,513 |
14,541,797 |
RGD:6480464 |
CTD |
| G |
Smoc2 |
SPARC related modular calcium binding 2 |
|
multiple interactions |
ISO |
17 |
14,416,513 |
14,541,797 |
RGD:6480464 |
CTD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
increases expression |
ISO |
16 |
10,783,901 |
10,785,629 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
EXP |
5 |
52,755,043 |
52,760,977 |
RGD:6480464 |
CTD |
| G |
Sost |
sclerostin |
|
multiple interactions |
ISO |
11 |
101,823,772 |
101,828,329 |
RGD:6480464 |
CTD |
| G |
Sox11 |
SRY-box containing gene 11 |
|
decreases expression |
ISO |
12 |
28,019,133 |
28,027,583 |
RGD:6480464 |
CTD |
| G |
Sox2 |
SRY-box containing gene 2 |
|
multiple interactions |
ISO |
3 |
34,548,927 |
34,551,383 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY-box containing gene 9 |
|
multiple interactions |
ISO |
11 |
112,643,524 |
112,649,071 |
RGD:6480464 |
CTD |
| G |
Tjap1 |
tight junction associated protein 1 |
|
decreases expression |
ISO |
17 |
46,394,825 |
46,419,962 |
RGD:6480464 |
CTD |
| G |
Tjap1 |
tight junction associated protein 1 |
|
multiple interactions |
ISO |
17 |
46,394,825 |
46,419,962 |
RGD:6480464 |
CTD |
| G |
Tle4 |
transducin-like enhancer of split 4, homolog of Drosophila E(spl) |
|
decreases expression |
ISO |
19 |
14,522,562 |
14,672,473 |
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
decreases expression |
ISO |
8 |
46,481,019 |
46,495,893 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like gene family 5 |
|
multiple interactions |
ISO |
7 |
125,740,811 |
125,818,599 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases activity |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Ugt2a1 |
UDP glucuronosyltransferase 2 family, polypeptide A1 |
|
affects expression |
ISO |
5 |
87,888,515 |
87,919,896 |
RGD:6480464 |
CTD |
| G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
affects expression |
ISO |
5 |
87,345,664 |
87,355,528 |
RGD:6480464 |
CTD |
| G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
increases expression |
ISO |
5 |
87,345,664 |
87,355,528 |
RGD:6480464 |
CTD |
| G |
Usp3 |
ubiquitin specific peptidase 3 |
|
increases expression |
ISO |
9 |
66,365,688 |
66,440,787 |
RGD:6480464 |
CTD |
| G |
Vangl1 |
vang-like 1 (van gogh, Drosophila) |
|
decreases expression |
ISO |
3 |
101,960,618 |
102,008,616 |
RGD:6480464 |
CTD |
| G |
Vangl1 |
vang-like 1 (van gogh, Drosophila) |
|
multiple interactions |
ISO |
3 |
101,960,618 |
102,008,616 |
RGD:6480464 |
CTD |
| G |
Vasp |
vasodilator-stimulated phosphoprotein |
|
decreases expression |
ISO |
7 |
19,842,278 |
19,857,203 |
RGD:6480464 |
CTD |
| G |
Vasp |
vasodilator-stimulated phosphoprotein |
|
multiple interactions |
ISO |
7 |
19,842,278 |
19,857,203 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
multiple interactions |
EXP |
13 |
89,794,915 |
89,882,117 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
increases expression |
EXP |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
multiple interactions |
EXP |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases secretion |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Wfdc1 |
WAP four-disulfide core domain 1 |
|
decreases expression |
ISO |
8 |
122,190,265 |
122,211,920 |
RGD:6480464 |
CTD |
| G |
Wfs1 |
Wolfram syndrome 1 homolog (human) |
|
increases expression |
ISO |
5 |
37,357,343 |
37,380,221 |
RGD:6480464 |
CTD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
multiple interactions |
ISO |
10 |
120,471,060 |
120,537,698 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
multiple interactions |
EXP |
2 |
163,646,570 |
163,658,882 |
RGD:6480464 |
CTD |
| G |
Wnk4 |
WNK lysine deficient protein kinase 4 |
|
increases expression |
EXP |
11 |
101,121,881 |
101,138,723 |
RGD:6480464 |
CTD |
| G |
Wnt3a |
wingless-related MMTV integration site 3A |
|
multiple interactions |
EXP |
11 |
59,061,538 |
59,104,253 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-related MMTV integration site 4 |
|
decreases expression |
ISO |
4 |
136,833,550 |
136,852,694 |
RGD:6480464 |
CTD |
Term paths to the root
|